ES11: Bridging the Gap: Clinical Trials in Asian and Western Lung Cancer Populations
Tracks
Saigon 1 Ballroom
| Saturday, October 11, 2025 |
| 11:30 AM - 12:30 PM |
Details
This session will present a premier platform bridging the gap between leading researchers, renowned clinicians, and industry professionals across Asia, Europe, and USA through collaborative networking and cutting-edge innovation to reframe the advancement of clinical research. We will thoroughly review the historical background, current progress, and future directions of lung cancer clinical research from both Eastern and Western perspectives, also addressing regional disparities in lung cancer diagnosis and treatment while promoting comprehensive and coordinated development for clinical trials.
Presentations followed by panel discussion and audience Q&A.
Speaker
Feng-Ming (Spring) Kong
Conference Chair
Session Chair
11:30 AM - 11:32 AM
Yi-Long Wu
Guangdong Lung Cancer Institute
ES11.01: Asia Contributions for Changing Global Clinical Practice of Lung Cancer
11:32 AM - 11:44 AM
Jose Berlderbos
Netherlands Cancer Institute
ES11.02: History, Current and Future Directions of Lung Cancer Clinical Trials from Europe (EORTC and ESMO)
11:44 AM - 11:56 AM
Walter Curran
Piedmont Oncology
ES11.03: History, Current and Future Directions of Lung Cancer Clinical Trials from the United States (NRG Oncology, SWOG, and Alliance)
11:56 AM - 12:08 PM
Hidehito Horinouchi
National Cancer Center Hospital
ES11.04: ATLAS
12:08 PM - 12:20 PM
